ISG15 and viral infectious disease: ISG15 has been proposed as an efficient host effector that defends against viral infections including that of human cytomegalovirus [17], human immune deficiency virus (HIV) [23], West Nile virus [24], and porcine reproductive and respiratory syncytial virus [25].